(1998) Rollins College, Winter Park, FL
(1998-2002) U. of Miami (Miller) School of Medicine
Internship (Internal Medicine):
(2002-03) U. of Miami/Jackson Memorial Medical Center, Miami, FL
Residency (Internal Medicine):
(2003-05) U. of Miami/Jackson Memorial Medical Center, Miami, FL
Fellowship (Pulmonary and Critical Care Medicine):
(2005-08) U. of North Carolina, Chapel Hill, NC
Academic & Professional Titles: (2008-present)
Assistant Professor of Medicine
Director, Pulmonary Hypertension Program
Co-Medical Director, UNC Pulmonary Clinic
Office: 8005 Burnett-Womack Building
Our group is interested in clinical and translational research in the area of Pulmonary Arterial Hypertension (PAH). We are involved in numerous multicenter clinical trials investigating therapies for PAH, as well as investigator initiated studies examining the treatment of PAH in the setting of sarcoidosis, cirrhosis, and interstitial lung disease (pulmonary fibrosis). We are also investigating the role of inflammatory and procoagulant biomarkers in the pathogenesis and clinical manifestations of PAH.
Fares WH, Ford HJ, Ghio AJ, Aris RM. Safety and Feasibility of Obtaining Wedged PA Samples and Differential Distribution of Biomarkers in Pulmonary Hypertension. Pulm Circ. 2012 Oct;2(4):477-82.
Fares WH, Blanchard SK, Stouffer GA, Chang PP, Rosamond WD, Aris RM, Ford HJ. Thermodilution and Fick Cardiac Outputs Differ: Impact on Pulmonary Hypertension Evaluation. Can Respir J. 2012 Jul-Aug;19(4):261-6.
Judson MA, Ford HJ, Aris RM, Donohue J, Burt S, Highland K, Craft N, Kwon S. Ambrisentan for Sarcoidosis Associated Pulmonary Hypertension. Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):139-45
Fares W, Ford HJ, Aris RM. Pulmonary Hypertension: Clinical Presentation, Diagnosis, Treatment, and Dana Point World Symposium Highlights. Current Resp Med Rev. 2011;7: 279-88.
Ford HJ, Roubey R. Pulmonary Manifestations of the Anti-phospholipid antibody syndrome. Clinics in Chest Medicine. 2010;31:537-45.
Ford HJ, Aris RM, Andreoni K. Screening for portopulmonary hypertension with transthoracic echocardiography: implications for early mortality associated with liver transplantation. Am J Respir Crit Care Med. 2009 Aug 15;180(4):378. (Letter to the Editor)
Wheless SA, Gulley ML, Raab-Traub N, McNeillie P, Neuringer IP, Ford HJ, Aris RM. Posttransplantation Lymphoproliferative Disorder: Epstein Barr Viral Loads, HLA A3, and Survival. Am J Respir Crit Care Med. 2008;178(10): 1060-5.